GENEVA, Dec. 1 -- THABOR THERAPEUTICS (4 rue Thenard75005 Paris) filed a patent application (PCT/EP2025/063879) for "OPTIMIZED ANTI-AGR2 ANTIBODY" on May 20, 2025. With publication no. WO/2025/242685, the details related to the patent application was published on Nov 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BEQ, Stephanie (4 rue Thenard75005 Paris), LEGER, Olivier (603 route des Luches74800 Saint Sixt)
Abstract: The present invention relates to the field of immunotherapy. In particular, the present invention relates to an antibody, or binding fragment thereof, that specifically b...